<SEC-DOCUMENT>0000905718-22-000551.txt : 20220407
<SEC-HEADER>0000905718-22-000551.hdr.sgml : 20220407
<ACCEPTANCE-DATETIME>20220407163932
ACCESSION NUMBER:		0000905718-22-000551
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220407
DATE AS OF CHANGE:		20220407
GROUP MEMBERS:		ABINGWORTH BIOVENTURES 8, LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001831828
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				812744449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92556
		FILM NUMBER:		22814348

	BUSINESS ADDRESS:	
		STREET 1:		8000 MARINA BOULEVARD, SUITE 120
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		650-770-0077

	MAIL ADDRESS:	
		STREET 1:		8000 MARINA BOULEVARD, SUITE 120
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Abingworth LLP
		CENTRAL INDEX KEY:			0001397144
		IRS NUMBER:				980518585
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		38 JERMYN STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 6DN
		BUSINESS PHONE:		44 (0)20 7534 1500

	MAIL ADDRESS:	
		STREET 1:		38 JERMYN STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 6DN
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>veratherap_sc13da1mar282022.htm
<DESCRIPTION>AMENDMENT NO.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 13D</B></P>

<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Under the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Amendment No. 1)</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.75pt solid">Vera Therapeutics,
Inc.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Issuer)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.75pt solid">Class A common stock,
par value $0.001 per share</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Title of Class of Securities)</P>

<DIV STYLE="padding: 0in 0in 1pt; border-bottom: Black 0.75pt solid">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">92337R 101</P>

</DIV>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(CUSIP Number)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">John Heard</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Abingworth LLP</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Princes House</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">38 Jermyn Street</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">London, England SW1Y 6DN</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">+44 20 7534 1500</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-top: Black 0.75pt solid">(Name, Address and
Telephone Number of Person</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Authorized to Receive Notices and Communications)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.75pt solid">March 28, 2022</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Date of Event which Requires Filing of this Statement)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the filing person has previously filed a statement
on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of <FONT STYLE="font-family: Playbill">&sect;&sect;</FONT>
240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. <FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Note</B>: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See <FONT STYLE="font-family: Playbill">&sect;</FONT>
240.13d-7 for other parties to whom copies are to be sent.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">*The remainder of this cover page shall be filled
out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information required on the remainder of this
cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934 (&#8220;Act&#8221;)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="9" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 7pt"><FONT STYLE="font-size: 11pt">CUSIP No. 92337R 101</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">1.</FONT></TD>
    <TD COLSPAN="7" STYLE="padding: 0.5pt 6.25pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0"><FONT STYLE="font-size: 11pt">Names of Reporting Persons. </FONT><FONT STYLE="font-size: 10pt">I.R.S.
    Identification Nos. of above persons (entities only):</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0 0">Abingworth LLP</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt">98-0518585</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 6.25pt 0.5pt"><FONT STYLE="font-size: 11pt">2.</FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 6.25pt 0.5pt"><FONT STYLE="font-size: 11pt">Check the Appropriate Box if a Member of a Group (See Instructions): </FONT></TD>
    <TD STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 6.25pt 0.5pt"><FONT STYLE="font-size: 11pt">(a) [ ]</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; padding: 7pt 6.25pt 0.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="padding: 0.5pt 6.25pt 6.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt 6.25pt 6.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">(b) [ ]</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 6.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">3.</FONT></TD>
    <TD COLSPAN="7" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">SEC Use Only</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">4.</FONT></TD>
    <TD COLSPAN="7" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Source of Funds (See Instructions): WC (See Item 3)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">5.</FONT></TD>
    <TD COLSPAN="7" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): [ ]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">6.</FONT></TD>
    <TD COLSPAN="7" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">Citizenship or Place of Organization: England</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="9" STYLE="border-top: black 1pt solid; padding: 1pt 6.25pt 0.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Number of</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">7. Sole Voting Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">0 </FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Shares Beneficially</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">8. Shared Voting Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">2,970,156*</FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Owned by</FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Each Reporting</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">9. Sole Dispositive Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">0 </FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Person With</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">10. Shared Dispositive Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">2,970,156*</FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 6.5pt 0.5pt 7pt"><FONT STYLE="font-size: 11pt">11.</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 6.5pt 0.5pt 7pt"><FONT STYLE="font-size: 11pt">Aggregate Amount Beneficially Owned by Each Reporting Person:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 6.5pt 0.5pt 7pt; text-align: right"><FONT STYLE="font-size: 11pt">2,970,156*</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 7pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">12.</FONT></TD>
    <TD COLSPAN="7" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): [ ]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">13.</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">Percent of Class Represented by Amount in Row (11): 11.1%*</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; padding: 7pt 0.5pt 6.5pt">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt 6.25pt 6.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">14.</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">Type of Reporting Person (See Instructions): PN</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding: 7pt 0.5pt">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding: 1pt 6.25pt 7pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 2%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 33%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 45%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 14%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 2%; padding: 0.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">*As of the date hereof, Abingworth LLP may be
deemed to beneficially own an aggregate of 2,970,156 shares of Class A common stock, par value $0.001 per share (the
&#8220;<U>Common Stock</U>&#8221;), of Vera Therapeutics, Inc. (the &#8220;<U>Issuer</U>&#8221;) consisting of (i) 2,960,231 shares
of Common Stock held by Abingworth Bioventures 8 LP (&#8220;<U>Abingworth 8</U>&#8221;) and (ii) 9,925 shares of Common Stock
issuable upon the exercise of a stock option (the &#8220;<U>Option</U>&#8221;) issued to Kurt von Emster. Mr. von Emster, a Partner
of Abingworth LLP, was granted the Option, as director&#8217;s compensation, which Option is fully exercisable within sixty (60)
days of the date hereof. Under an agreement between Mr. von Emster and Abingworth LLP, Mr. von Emster is deemed to hold the Option
and any shares of Common Stock issuable upon the exercise of the Option for the benefit of Abingworth 8, and must exercise the
Option solely upon the direction of Abingworth LLP. As a result of the foregoing, Abingworth LLP, as the investment manager of
Abingworth 8, may be deemed to beneficially own (i) the 2,960,231 shares of Common Stock held by Abingworth 8 and (ii) the 9,925
shares of Common Stock issuable upon the exercise of the Option. Thus, for purposes of Rule 13d-3 under the Securities Exchange Act
of 1934, as amended, Abingworth LLP may be deemed to beneficially own 11.1% of the shares of Common Stock of the Issuer deemed
issued and outstanding as of the date hereof.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foregoing beneficial ownership percentage
is based upon 26,743,289 shares of Common Stock issued and outstanding as of the date hereof, based on information reported in the Issuer&#8217;s
Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2022.</P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="9" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 7pt"><FONT STYLE="font-size: 11pt">CUSIP No. 92337R 101</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">1.</FONT></TD>
    <TD COLSPAN="7" STYLE="padding: 0.5pt 6.25pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0"><FONT STYLE="font-size: 11pt">Names of Reporting Persons. </FONT><FONT STYLE="font-size: 10pt">I.R.S.
    Identification Nos. of above persons (entities only):</FONT></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0 0">Abingworth Bioventures 8, LP</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 6.25pt 0.5pt"><FONT STYLE="font-size: 11pt">2.</FONT></TD>
    <TD COLSPAN="4" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 6.25pt 0.5pt"><FONT STYLE="font-size: 11pt">Check the Appropriate Box if a Member of a Group (See Instructions): </FONT></TD>
    <TD STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 6.25pt 0.5pt"><FONT STYLE="font-size: 11pt">(a) [ ]</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; padding: 7pt 6.25pt 0.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="padding: 0.5pt 6.25pt 6.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt 6.25pt 6.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">(b) [ ]</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 6.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">3.</FONT></TD>
    <TD COLSPAN="7" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">SEC Use Only</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">4.</FONT></TD>
    <TD COLSPAN="7" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Source of Funds (See Instructions): WC (See Item 3)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">5.</FONT></TD>
    <TD COLSPAN="7" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): [ ]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">6.</FONT></TD>
    <TD COLSPAN="7" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">Citizenship or Place of Organization: England</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="9" STYLE="border-top: black 1pt solid; padding: 1pt 6.25pt 0.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Number of</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">7. Sole Voting Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">0 </FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Shares Beneficially</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">8. Shared Voting Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">2,970,156*</FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Owned by</FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Each Reporting</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">9. Sole Dispositive Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">0 </FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.5pt 6.25pt 3.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Person With</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt"><FONT STYLE="font-size: 11pt">10. Shared Dispositive Power:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.5pt 6.25pt 4pt; text-align: right"><FONT STYLE="font-size: 11pt">2,970,156*</FONT></TD>
    <TD STYLE="padding: 0.5pt 6.25pt 3.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 6.5pt 0.5pt 7pt"><FONT STYLE="font-size: 11pt">11.</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 6.5pt 0.5pt 7pt"><FONT STYLE="font-size: 11pt">Aggregate Amount Beneficially Owned by Each Reporting Person:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 6.5pt 0.5pt 7pt; text-align: right"><FONT STYLE="font-size: 11pt">2,970,156*</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.5pt 6.25pt 7pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">12.</FONT></TD>
    <TD COLSPAN="7" STYLE="padding: 6.5pt 0.5pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): [ ]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">13.</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt 6.5pt"><FONT STYLE="font-size: 11pt">Percent of Class Represented by Amount in Row (11): 11.1%*</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; padding: 7pt 0.5pt 6.5pt">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt 6.25pt 6.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">14.</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 7pt 0.5pt"><FONT STYLE="font-size: 11pt">Type of Reporting Person (See Instructions): PN</FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding: 7pt 0.5pt">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; padding: 1pt 6.25pt 7pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 2%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 33%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 45%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 14%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 2%; padding: 0.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;* As of the date hereof, Abingworth Bioventures
8 LP (&#8220;<U>Abingworth 8</U>&#8221;) may be deemed to beneficially own an aggregate of 2,970,156 shares of Class A common stock,
par value $0.001 per share (the &#8220;<U>Common Stock</U>&#8221;), of Vera Therapeutics, Inc. (the &#8220;<U>Issuer</U>&#8221;) consisting
of (i) 2,960,231 shares of Common Stock held by Abingworth 8 and (ii) 9,925 shares of Common Stock issuable upon the exercise of a stock
option (the &#8220;<U>Option</U>&#8221;) issued to Kurt von Emster. Mr. von Emster, a Partner of Abingworth LLP, was granted the Option,
as director&#8217;s compensation, which Option is fully exercisable within sixty (60) days of the date hereof. Under an agreement between
Mr. von Emster and Abingworth LLP, Mr. von Emster is deemed to hold the Option and any shares of Common Stock issuable upon the exercise
of the Option for the benefit of Abingworth 8, and must exercise the Option solely upon the direction of Abingworth LLP. As a result
of the foregoing, Abingworth 8 may be deemed to beneficially own (i) the 2,960,231 shares of Common Stock held by Abingworth 8 and (ii)
the 9,925 shares of Common Stock issuable upon the exercise of the Option. Thus, for purposes of
Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Abingworth 8 may be deemed to beneficially own 11.1% of the shares of
Common Stock of the Issuer deemed issued and outstanding as of the date hereof.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foregoing beneficial ownership percentage
is based upon 26,743,289 shares of Common Stock issued and outstanding as of the date hereof, based on information reported in the Issuer&#8217;s
Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2022.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><B>Explanatory Note</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify; text-indent: 1in">This Amendment No. 1 (this
&#8220;<U>Amendment</U>&#8221;) amends and supplements the Schedule 13D filed on behalf of the Reporting Persons with the Securities and
Exchange Commission on May 24, 2021 (the &#8220;<U>Schedule 13D</U>&#8221;). Except as specifically provided herein, this Amendment does
not modify or amend any of the information previously reported in the Schedule 13D. Capitalized terms used and not otherwise defined herein
shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to each item shall be deemed incorporated
by reference in all other items, as applicable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Item 1.&#9;<U>Security and Issuer</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Item 1 of the Schedule 13D is amended and restated
as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">This Schedule 13D relates to the
Class A common stock, par value $0.001 per share (the &#8220;<U>Common Stock</U>&#8221;), of Vera Therapeutics, Inc., a Delaware corporation
(the &#8220;<U>Issuer</U>&#8221;). The principal executive offices of the Issuer are located at 8000 Marina Boulevard, Suite 102, Brisbane,
California 94005.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 5.</TD><TD><U>Interest in Securities of the Issuer</U></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Item 5 of the Schedule 13D is amended and restated as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">As of the date hereof, Abingworth
LLP may be deemed to beneficially own an aggregate of 2,970,156 shares of Common Stock of the Issuer consisting of (i) 2,960,231 shares
of Common Stock held by Abingworth 8 and (ii) 9,925 shares of Common Stock issuable upon the exercise of the Option. Under an agreement
between Mr. von Emster and Abingworth LLP, Mr. von Emster is deemed to hold the Option and any shares of Common Stock issuable upon the
exercise of the Option for the benefit of Abingworth 8, and must exercise the Option solely upon the direction of Abingworth LLP.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">As a result of the foregoing, Abingworth
LLP, as the investment manager of Abingworth 8, may be deemed to beneficially own (i) the 2,960,231 shares of Common Stock held by Abingworth
8 and (ii) the 9,925 shares of Common Stock issuable upon the exercise of the Option. Thus, for purposes of Rule 13d-3 under the Securities
Exchange Act of 1934, as amended, Abingworth LLP may be deemed to beneficially own 11.1% of the shares of Common Stock of the Issuer deemed
issued and outstanding as of the date hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">The foregoing beneficial ownership
percentage is based upon 26,743,289 shares of Common Stock issued and outstanding as of the date hereof, based on information reported
in the Issuer&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2022.</P>

<P STYLE="font: 11pt/14pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">Except as described herein, during
the past sixty (60) days on or prior to the date hereof, there were no other purchases or sales of shares of Common Stock, or securities
convertible into or exchangeable for shares of Common Stock, by the Reporting Persons or any person or entity for which the Reporting
Persons possess voting or dispositive control over the securities thereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: -1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/200% Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Signature</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement is true, complete and correct.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Dated: April 7, 2022</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 3.5in"><B>ABINGWORTH BIOVENTURES 8 LP</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 3.5in">By: Abingworth LLP, its Manager</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">By:<U>&#9;/s/ John Heard&#9;</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.25in">Name: John Heard</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.25in">Title: Authorized Signatory</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-indent: 0.5in"><B>ABINGWORTH LLP</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">By:<U>&#9;/s/ John Heard&#9;</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.25in">Name: John Heard</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.25in">Title: Authorized Signatory</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Attention: Intentional misstatements or omissions
of fact constitute Federal criminal violations (See 18 U.S.C. 1001).</B></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
